Estrella Immunopharma ESLA
NASDAQ ESLA
$0.47 -0.01 (-1.47%)
At close: Oct 2, 2026 · 4:00 PM EDT

Estrella Immunopharma (ESLA) Net Equity Issued and Repurchased (2021 - 2026)

Updated

Estrella Immunopharma (ESLA) posted Net Equity Issued and Repurchased of $8 million for Q1 2026.

Analysis

Estrella Immunopharma (ESLA) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends

For FY2025, Estrella Immunopharma's Net Equity Issued and Repurchased came in at $2.4 million.

  • Annual Net Equity Issued and Repurchased shows a four-year compound annual growth rate of -6.4% (FY2021 to FY2025).
  • In prior years, Estrella Immunopharma's Net Equity Issued and Repurchased was $79,491 in FY2024 and $3.12 million in FY2021.
  • The Q1 2026 figure stands as the lowest quarterly Net Equity Issued and Repurchased since Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 6.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 9.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Estrella Immunopharma 20.44 Mn 15.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 8.00 Mn
Sep 30, 2021 3.10 Mn
Mar 31, 2021 25,000.00
API Access

Estrella Immunopharma Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ESLA&period=max&api_key=YOUR_API_KEY